跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARIPIPRAZOL MYLAN PHARMA 5 mg COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ARIPIPRAZOL MYLAN PHARMA 5 mg COMPRIMIDOS EFG
Approved
STANDARD
ARIPIPRAZOL MYLAN PHARMA 5 mg COMPRIMIDOS EFG
Mylan Pharmaceuticals Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 21, 2021
Approval ID
09f6faa3bb182f04
Company
Mylan Pharmaceuticals Limited
Type
Standard
Approval Details
Approval Id
09f6faa3bb182f04
Drug Cima Aemps Name
ARIPIPRAZOL MYLAN PHARMA 5 mg COMPRIMIDOS EFG
Register Number
1151005002
Holder Company Name
Mylan Pharmaceuticals Limited
Marketing Company Name
Viatris Pharmaceuticals S.L.U.
Holder Company Detail Path
/organization/mylan-pharmaceuticals-private-limited
Authorization Date
2021-05-21
Dosage Form
COMPRIMIDO
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Mylan Pharmaceuticals Limited
Company Detail Path
/organization/mylan-pharmaceuticals-private-limited
Company Information
Pharmaceutical Company Name
MYLAN PHARMACEUTICALS PRIVATE LIMITED
Country Name
India
City Name
patna,bihar,country_in
Address
Mylan Pharmaceuticals Pvt Ltd, Plot No A-6 and A-7, C/o Shree
Active Ingredients
ARIPIPRAZOL
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 21, 2021
Approval ID
09f6faa3bb182f04
Type
Standard
Back to CIMA-AEMPS Approvals